Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Plex Pharmaceuticals, Inc. in February, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI145617-01A1 | Phase I | 300,000 | February 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Plex Pharmaceuticals, Inc. in July, 2020 for $149,295.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43EY031609-01 | Phase I | 149,295 | July 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Plex Pharmaceuticals, Inc. in July, 2020 for $662,896.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44EY027236-03 | Phase II | 662,896 | July 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Plex Pharmaceuticals, Inc. in September, 2016 for $299,173.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EY027236-01 | Phase I | 299,173 | September 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Plex Pharmaceuticals, Inc. in May, 2014 for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI114084-01 | Phase I | 600,000 | May 15, 2014 | |||||||
A SBIR Phase I contract was awarded to Plex Pharmaceuticals, Inc. for $279,068.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM090383-01A1 | Phase I | 279,068 | ||||||||
A SBIR Phase I contract was awarded to Plex Pharmaceuticals, Inc. for $201,930.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK088457-01 | Phase I | 201,930 |